Symptom Assessment in Dry Eye (SANDE) Changes from baseline up to day 56±4 [clinicaltrials_resource:2291a04c2ae4f3c0892f23ee160f7fa2]
20 patients will be treated with the first planned dose, i.e. 20 µg/mL
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Symptom Assessment in Dry Eye (SANDE) Changes from baseline up to day 56±4 [clinicaltrials_resource:2291a04c2ae4f3c0892f23ee160f7fa2]
20 patients will be treated with the first planned dose, i.e. 20 µg/mL
Bio2RDF identifier
2291a04c2ae4f3c0892f23ee160f7fa2
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:2291a04c2ae4f3c0892f23ee160f7fa2
measure [clinicaltrials_vocabulary:measure]
Symptom Assessment in Dry Eye (SANDE)
time frame [clinicaltrials_vocabulary:time-frame]
Changes from baseline up to day 56±4
description
20 patients will be treated with the first planned dose, i.e. 20 µg/mL
identifier
clinicaltrials_resource:2291a04c2ae4f3c0892f23ee160f7fa2
title
Symptom Assessment in Dry Eye (SANDE) Changes from baseline up to day 56±4
@en
type
label
Symptom Assessment in Dry Eye ...... 1a04c2ae4f3c0892f23ee160f7fa2]
@en